Correlation Between Scpharmaceuticals and Biovie
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Biovie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Biovie into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Biovie Inc, you can compare the effects of market volatilities on Scpharmaceuticals and Biovie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Biovie. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Biovie.
Diversification Opportunities for Scpharmaceuticals and Biovie
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Scpharmaceuticals and Biovie is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Biovie Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biovie Inc and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Biovie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biovie Inc has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Biovie go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Biovie
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Biovie. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 1.23 times less risky than Biovie. The stock trades about -0.11 of its potential returns per unit of risk. The Biovie Inc is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 274.00 in Biovie Inc on September 1, 2024 and sell it today you would lose (3.00) from holding Biovie Inc or give up 1.09% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Biovie Inc
Performance |
| Timeline |
| Scpharmaceuticals |
| Biovie Inc |
Scpharmaceuticals and Biovie Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Biovie
The main advantage of trading using opposite Scpharmaceuticals and Biovie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Biovie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biovie will offset losses from the drop in Biovie's long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Biovie vs. Tff Pharmaceuticals | Biovie vs. Eliem Therapeutics | Biovie vs. Inhibrx | Biovie vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |